GlassScriptPhysician profile
Jason Robert Hall
NPI 1003223983
$6,205.83
in general payments reported to CMS, 2019-2025
12 companies · $1,585 in 2025
The $1,585 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $170 · 2021: $1,728 · 2022: $264 · 2023: $2,139 · 2024: $320 · 2025: $1,585.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,237 · Food and Beverage: $1,807.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,237.24 |
| Food and Beverage | $1,806.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,827.64 | 2021-2025 | Pivox Oblique Lateral Spinal System, Mazor X System, Unid_pass |
| Medical Device Business Services, INC. | $1,347.54 | 2019-2021 | |
| Abbott Laboratories | $373.03 | 2023-2025 | Proclaim, Eterna |
| Si-Bone, INC. | $303.42 | 2022-2023 | |
| Depuy Synthes Sales INC. | $168.60 | 2021 | |
| Gt Medical Technologies, INC | $67.23 | 2025 | Gammatile |
| Ucb, INC. | $23.47 | 2025 | Zilbrysq |
| Otsuka America Pharmaceutical, INC. | $22.00 | 2025 | Rexulti |
| Genentech USA, INC. | $20.82 | 2025 | Ocrevus Zunovo |
| Janssen Biotech, INC. | $18.12 | 2025 | |
| Providence Medical Technology, INC. | $17.82 | 2025 | |
| Csl Behring | $16.14 | 2025 | Kcentra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.